Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
1 participants
OBSERVATIONAL
2017-11-30
2022-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measuring Hand Edema in Burn Patients
NCT00137228
Study of Idiopathic Edema
NCT01681927
Bedside Ultrasound Identifies Congestive Heart Failure
NCT00833144
Echocardiographic Examination Performed by Nurses in Cardiac Intensive Care Unit
NCT00886548
Correlation of Clinical and Laboratory Findings and Diuretic Efficacy in Patients With Edematous States in the Emergency Department
NCT03967717
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Once patients and clinicians have been recruited, the research team will maintain a list of the patients and a grid of which clinicians are to examine which patients. Each clinician will be given a data collection sheet, listing the patients' room numbers, and a grid for recording results for each of the patient's affected limb(s). The first data collection sheet (before instruction on the quantitative method) will just show a blank free text field so that clinicians can record their results as they normally do.
After instruction in the novel quantitative technique, the clinicians will receive another data collection sheet now indicating the intent to have the clinicians record their findings in millimeters.
The expectation is that a minimum of 6 examiners will determine the extent of edema on at least 38 limbs. If possible, the research will continue until approximately 100 limbs have been examined by a total of at least 10 to 20 clinicians.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exam for quantity of edema
There is no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient who can understand the purpose of the study and sign a consent form
* Patient has a measurable amount of edema
* Patient will likely be available during the time the clinicians can examine the patient
Exclusion Criteria
* No measurable edema
* Currently in isolation for infection control purposes
* Patients in the Behavioral Health section of the hospital
* Maternity patients (due to availability of infant rooming-in)
* Prisoners
* Age below 18 years
* Patients with bilateral lower extremity amputation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Geisinger Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Richard Schreiber, MD FACP
Chief Medical Informatics Officer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard Schreiber, MD
Role: PRINCIPAL_INVESTIGATOR
Geisinger Holy Spirit
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Geisinger Holy Spirit
Camp Hill, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-0434
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.